-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
ppar
-
An $8 million clinical trial of ASP0367 for patients with poor systemic oxygen extraction
A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction The purpose of this study is to to evaluate the effect of ASP0367 on improvement of aerobic capacity relative to placebo, as well as evaluate the safety and tolerability of...- Hoopoe
- Thread
- asp0367 ppar systemic oxygen extraction
- Replies: 5
- Forum: ME/CFS research news